Pedro Rodriguez Cutillas

Kinomica Ltd. develops anti-cancer drug therapies. The company is based in Macclesfield, UK. The British company was founded in 2016 by David Britton, Pedro Rodriguez Cutillas. The CEO is Jane Theaker.

Pronostics Ltd. operates as a clinical diagnostics company. It offers diagnostic and disease monitoring applications. The company’s products include UltraPlex line of automated multiplexing solutions, such as UltraPlex multiplexed assays to multiplex a range of assays for applications in direct immunoassay; and UltraPlex ANA, a barcoded immunoassay for testing of autoimmune disease biomarkers that allows hospitals and laboratories to perform automated profiles of patient. The company was founded in 2000 and is headquartered in Cambridge, the United Kingdom.

Part of St Bartholomew's Hospital Medical College, Barts Cancer Institute operates as a cancer research center. The company is based in London, UK.

The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom.

Activiomics Ltd. develops innovative technologies that utilize mass spectrometry to interrogate and interpret the activity of cellular signaling pathways. It offers phosphoproteomics for biomaker discovery and drug profiling. The company was founded by Bart Vanhaesebroeck and Pedro Rodriguez Cutillas in 2009 and is headquartered in London, the United Kingdom.